Midostaurin in Advanced Systemic Mastocytosis

To the Editor: Advanced systemic mastocytosis carries a poor prognosis. Midostaurin, an inhibitor of tyrosine kinases, targets KIT mutants associated with mastocytosis. The French National Reference Center for Mastocytosis (CEREMAST) conducted a prospective survey of patients with mastocytosis who…

from Cancer via ola Kala on Inoreader http://ift.tt/2922Hte
via IFTTT